In vitro modulation of rat adipocyte ghost membrane fluidity by cholesterol oxysterols.
The effects of cholesterol and cholesterol-derived oxysterols (cholestanone, cholestenone, coprostanone and epicoprostanol) on adipocyte ghost membrane fluidity were studied using a fluorescence depolarization method. The fluorescence anisotropy of the treated membranes was determined using 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH). Cholestanone and cholesterol decreased membrane fluidity at both the concentrations tested (10 & 50 microM) while the rest of the sterols did not exert any significant effect on membrane fluidity. In the presence of epinephrine, cholestanone partitioned more towards the lipid core but cholesterol partitioning was not affected. The fusion activation energies (delta E) obtained for membranes preincubated with cholestanone (8.6 kcal/mol) and cholesterol (8.2 kcal/mol) were not significantly different from that of untreated membranes (8.3 kcal/mol). Membranes preincubated with cholestanone and cholesterol did not exhibit any change in lipid phase throughout the temperature range (10-45 degrees C) tested. The sterols were found to inhibit fisetin-induced phospholipid methylation in isolated rat adipocytes in the rank order of cholesterol > epicoprostanol > cholestanone = cholestenone = coprostanone, while basal methylation was unaffected. When adipocytes were preincubated with the sterols before the addition of fisetin, cholestanone and cholestenone showed 74% and 66% inhibition of maximal methylation respectively. These results indicated that cholesterol oxysterols interact differently with rat adipocyte membranes, with cholestanone interacting more with phospholipids located at the inner lipid bilayer (e.g. phosphatidylethanolamine) while cholesterol interacts more with phosphatidylcholine located at the outer lipid bilayer. This differential interaction may cause selective changes in membrane fluidity at different depths of the bilayer and thus may modulate the activities of membrane-bound proteins such as enzymes and receptors.
Lau
W F
WF
Department of Biochemistry, Faculty of Medicine, National University of Singapore.
Das
N P
NP
D000273:Adipose Tissue / Q000187:drug effects*; D000818:Animals; D002776:Cholestanes / Q000494:pharmacology; D004083:Cholestanol / Q000494:pharmacology; D002778:Cholestanones / Q000494:pharmacology; D002783:Cholestenones / Q000494:pharmacology; D002784:Cholesterol / Q000494:pharmacology*; D005454:Fluorescence Polarization; D008297:Male; D008560:Membrane Fluidity / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar
D002776:Cholestanes; D002778:Cholestanones; D002783:Cholestenones; D004083:Cholestanol; D002784:Cholesterol; C007123:coprostanone